Skip to main content
SpringerLink
Log in

Les principaux agents et techniques d’analgésie par voie systémique

  • Chapter
Analgésie et sédation en réanimation

Part of the book series: Le point sur ... ((POINT))

  • 527 Accesses

Resume

À ce jour, aucun agent ne possède toutes les qualités requises (bonne tolérance hémodynamique et respiratoire, absence d’accumulation dans l’organisme, amnésie, anxiolyse) pour assurer une sédation et une analgésie idéale (1). Le choix des différents agents isolés ou en association répond à des critères d’analyse de la balance entre les bénéfices et les risques escomptés. L’usage consiste à associer un agent hypnotique et un analgésique. Le propofol et le midazolam sont les hypnotiques les plus utilisés en France. Parmi les opiacés, le rémifentanil possède l’avantage unique d’avoir une demi-vie d’élimination indépendante de la durée d’administration. La pharmacocinétique des agents utilisés pour la sédation analgésie est cependant profondément modifiée la plupart du temps chez les patients de réanimation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Young C, Knudsen N, Hilton A, Reves JG (2002) Sedation in the intensive care unit. Crit Care Med 28: 854–66

    Article  Google Scholar 

  2. Kay B, Rolly G ICI 35868 (1977) A new intravenous induction agent. Acta Anaesthesiol Belg 28: 303

    CAS  PubMed  Google Scholar 

  3. Albanese J, Martin C, Lacarelle B et al. (1990) Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients. Anesthesiology 73: 214–7

    Article  CAS  PubMed  Google Scholar 

  4. Barr J, Egan TD, Sandoval NF et al. (2000) Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model, Anesthesiology 195:324–3

    Google Scholar 

  5. Fudickar A, Bein B (2009) Propofol infusion syndrome: update of clinical manifestation and pathophysiology. Minerva Anestesiol. 75: 339–44

    CAS  PubMed  Google Scholar 

  6. Vasile B, Rasulo F, Candiani A, Latronico N (2003) The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome, Intensive Care Med 29: 1417–25

    Article  PubMed  Google Scholar 

  7. Wysowski DK, Pollock ML (2006) Reports of death with use of propofol (Diprivan®) for non-procedural (long-term) sedation and literature review, Anesthesiology 105: 1047–51

    Article  PubMed  Google Scholar 

  8. Payen J F, Chanques G, Mantz J B et al. (2007) Current practice in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient based study. Anesthesiology 106: 687–95

    Article  PubMed  Google Scholar 

  9. Ostermann ME, Keenan S P, Seiferling RA, Sibbald WJ (2000) Sedation in the intensive care unit: a systematic review, JAMA 283: 1451–9

    Article  CAS  PubMed  Google Scholar 

  10. Walder B, Elia N, Henzi I et al. (2001) A lack of evidence of superiority of propofol versus midazolam for sedation in mechanically ventilated critically ill patients: a qualitative and quantitative systematic review. Anesth Analg 92: 975–83

    Article  CAS  PubMed  Google Scholar 

  11. McMurray TJ, Johnston JR, Milligan KR et al. (2004) Propofol sedation using diprifusor target-controlled infusion in adult intensive care unit patients. Anaesthesia 59: 636–41

    Article  CAS  PubMed  Google Scholar 

  12. Hall RI, Sandham D, Cardinal P et al. (2001) Propofol vs midazolam for ICU sedation: a Canadian multicenter randomized trial. Chest 119: 1151–9

    Article  CAS  PubMed  Google Scholar 

  13. Kress J, Pohlman A, O’Connor M, Hall J (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342: 1471–7

    Article  CAS  PubMed  Google Scholar 

  14. Macdonald JF, Nowak LM (1990) Mechanisms of blockade of excitatory amino acid receptor channels. Trends Pharmocol Sci 11: 167–72

    Article  CAS  Google Scholar 

  15. Chudnofsky CR, Weber JE, Stoyanoff PJ et al. (2000) A combination of midazolam and ketamine for procedural sedation and analgesia in adult emergency department patients. Acad Emerg M 7: 863–80

    Google Scholar 

  16. Elia N, Tramer MR (2005) Ketamine and postoperative pain. A quantitative systematic review of randomized trials. Pain 113: 61–70

    Article  CAS  PubMed  Google Scholar 

  17. Clements JA, Nimmo WS (1981) Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth 53: 27–30

    Article  CAS  PubMed  Google Scholar 

  18. De Pinto M, Jelacic J, Edwards WT (2008) Very-low-dose ketamine for the management of pain and sedation in the ICU J Opioid Manag 4: 54–6

    PubMed  Google Scholar 

  19. Maze M, Bonnet F (2003) Receptor ligands a2 adrenergic receptor agonists. In Pharmacology basis of clinical practice. Maze M ed, Londres 473–89

    Google Scholar 

  20. Ip Yam PC, Forbes A, Kox WJ (1992) Clonidine in the treatment of alcohol withdrawal in the intensive care unit. Br J Anaesth. Jan; 68: 106–8

    Article  CAS  PubMed  Google Scholar 

  21. Pandharipande P P, Pun BT, Herr DL (2007) Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 298: 2644–53

    Article  CAS  PubMed  Google Scholar 

  22. Shehabi V, Ruettimann U, Adamson H et al. (2004) Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med 30: 2188–96

    Article  PubMed  Google Scholar 

  23. Gerlach AT, Dasta Joseph F (2007) Dexmedetomidine: an Updated Review. The Annals of Pharmacotherapy. Feb; 41: 245–53

    Article  CAS  PubMed  Google Scholar 

  24. Nunes S, Kaukonen M, Shepherd ST (2009) Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med 35: 282–90

    Article  PubMed  Google Scholar 

  25. Riker R, Shehabi Y, Bokesch PM (2009) Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients. JAMA. 31: 489–99

    Article  Google Scholar 

  26. Milbrandt EB, Kersten A, Kong L et al. (2005) Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med. 33: 226–9

    Article  CAS  PubMed  Google Scholar 

  27. Osborne R, Joel S, Grebenik T et al. (1993) The pharmacokinetics of morphine and morphine glucuronides in kidney failure. Clin Pharmacol Ther 54: 158–67

    Article  CAS  PubMed  Google Scholar 

  28. Murdoch S, Cohen A (2000) Intensive care sedation: a review of current British practices. Intensive Care Med 26: 922–8

    Article  CAS  PubMed  Google Scholar 

  29. Kapila A, Glass PSA, Jacobs JR et al. (1995) Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 83: 968–75

    Article  CAS  PubMed  Google Scholar 

  30. Rozendaal FW, Spronk PE, Snellen FF, Schoen A (2009) Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med 35: 291–8

    Article  CAS  PubMed  Google Scholar 

  31. Minto CF, Schnider TW, Egan TD et al. (1997) Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 86: 10–23

    Article  CAS  PubMed  Google Scholar 

  32. Carle CE, Goodall J (2009) Optimal dose and timing for perioperative morphine after remifentanil-based anaesthesia. Br J Hosp Med 70: 177

    CAS  Google Scholar 

  33. Viscusi ER, Gan TJ, Leslie JB et al. (2009) Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability. Anesth Analg. 108: 1811–22

    Article  CAS  PubMed  Google Scholar 

  34. Mitra S (2008) Opioid-induced hyperalgesia: pathophysiology and clinical implications. J Opioid Manag 4: 123–30

    PubMed  Google Scholar 

Download references

Authors
  1. V. Argo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Bonnet
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Argo, V., Bonnet, F. (2010). Les principaux agents et techniques d’analgésie par voie systémique. In: Analgésie et sédation en réanimation. Le point sur .... Springer, Paris. https://doi.org/10.1007/978-2-287-99029-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-99029-8_2

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-99028-1

  • Online ISBN: 978-2-287-99029-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation